Takeda Yakuhin Kogyo KK header image

Takeda Yakuhin Kogyo KK

TAK

Equity

ISIN null / Valor 11292411

New York Stock Exchange, Inc (2026-06-04)

USD 15.45+2.79%

Takeda Yakuhin Kogyo KK
UMushroom community rating:

5.00 2 votes No rating yet

NegativeNeutralPositive

About company

Takeda Yakuhin Kogyo K.K. is a Japanese pharmaceutical manufacturer that develops, produces and markets medicines and related chemical intermediates for healthcare markets, supplying hospitals, pharmacies and distributors at home and abroad. Its business combines research and formulation work with commercial manufacturing—covering active pharmaceutical ingredient production, finished‑dose formulation, quality control and regulatory compliance—and it also provides contract manufacturing and outsourcing services to other drugmakers. The company’s product mix spans prescription (ethical) medicines, consumer health/OTC products and bulk pharmaceutical ingredients, with operations organized to support manufacturing scale, supply‑chain reliability and customer distribution channels.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

2.79%1Y

-4.16%3Y

-7.60%5Y

Performance

19.6%1Y

19.0%3Y

19.6%5Y

Volatility

48810 M

Market cap (USD)

2,653,466

Daily traded volume (Shares)

13.25 / 13.155

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

2 votes

Performance:

4.00

Innovation:

3.00

Society:

3.00

Nature:

3.00

Adam Hakimi Bin Hasni

United Kingdom, 04 Nov 2025

A good company for long term investment as pharmaceutical and healthcare is a much needed service in Japan

sofia nava

Switzerland, 29 Oct 2025

.

EQUITIES OF THE SAME SECTOR

Sanofi SA

Sanofi SA Valor: 699381

Annual Return

-50%0%+50%

Risk level

110

3.97%EUR 76.44

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

4.17%CHF 324.60

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-2.24%USD 20.07

Galenica Ltd.

Galenica Ltd. Valor: 36067446

Annual Return

-50%0%+50%

Risk level

110

1.09%CHF 83.30

Idorsia Ltd

Idorsia Ltd Valor: 36346343

Annual Return

-50%0%+50%

Risk level

110

9.77%CHF 4.45

Alkermes PLC

Alkermes PLC Valor: 13920929

Annual Return

-50%0%+50%

Risk level

110

1.45%USD 43.38

Medacta Group Ltd

Medacta Group Ltd Valor: 46852522

Annual Return

-50%0%+50%

Risk level

110

1.47%CHF 137.80

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

2.44%USD 20.14

SHL Telemedicine Ltd

SHL Telemedicine Ltd Valor: 1128957

Annual Return

-50%0%+50%

Risk level

110

0.00%CHF 1.00

RHOEN-KLINIKUM AG

RHOEN-KLINIKUM AG Valor: 341644

Annual Return

-50%0%+50%

Risk level

110

0.81%EUR 12.40

SIX

FactSet

Clearbit

Logos provided by Clearbit